Skip to content

The model construction of curative effect observation and early prediction for the post-stroke cognitive impairment with the acupuncture interventional treatment at different time points

The model construction of curative effect observation and early prediction for the post-stroke cognitive impairment with the acupuncture interventional treatment at different time points

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001490
Enrollment
Unknown
Registered
2025-07-26
Start date
2024-10-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke cognitive impairment

Interventions

Conventional acupuncture group:Acupuncture treatment administered 30 days post-stroke
Control group: Conventional Western medical treatment no acupuncture
Ultra-early intervention group:Acupuncture treatment administered 7 days post-stroke
Early intervention group:Acupuncture treatment administered 14 days post-stroke

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Diagnosed with ischemic stroke onset within 6 months; (2) Aged 30-75 years with an education level of at least elementary school; (3) Capable of daily living activities with a Barthel index of =60; (4) No cognitive function abnormalities at enrollment with a Montreal Cognitive Assessment (MoCA) score of =18; (5) Mini-Mental State Examination (MMSE): MMSE score >17 (illiterate) or MMSE score >20 (elementary school level) or MMSE score >24 (middle school level or higher); (6) The patient must sign an informed consent form and cooperate with the treatment.

Exclusion criteria

Exclusion criteria: (1) Patients diagnosed with cognitive impairment before cerebral infarction; (2) Patients currently taking medications that may interfere with the evaluation of the efficacy of the study treatment including cholinesterase inhibitors cytosine or those who have received traditional Chinese medicine or acupuncture treatment before enrollment; (3) Patients who are unable to complete the assessment due to severe mental cognitive or emotional disorders during the screening process; (4) Patients with severe diseases of the heart liver kidneys or other organs; (5) Pregnant women planning to become pregnant or breastfeeding women; (6) Patients recruited to participate in other clinical trials related to acupuncture or cognitive impairment within the last month.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment (MoCA);"Incidence of PSCI";Mini-mental State Examination;

Secondary

MeasureTime frame
Activities of daily living ADL;quality of life score QOL;Changes in MRI brain networks;Hamilton Depression Rating Scale;Brunnstrom Movement Therapy;Fugl Meyer Assessment;Issues Diagnosis Scale for Ischemic Stroke Symptoms;Hamilton Anxiety Rating Scale;

Countries

China

Contacts

Public ContactRuiwen Fan

Peking University Third Hospital

frw9606@163.com010-82264623

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026